The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
An ongoing phase IIIb/IV safety trial of nivolumab (NIVO) in patients (pts) with advanced or metastatic non-small-cell lung cancer (NSCLC) who progressed after receiving 1 or more prior systemic regimens.
 
Todd Michael Bauer
Research Funding - Bristol-Myers Squibb (Inst)
 
Michael McCleod
No Relationships to Disclose
 
Jason Claud Chandler
Consulting or Advisory Role - Alexion Pharmaceuticals; Bristol-Myers Squibb; Onyx
Travel, Accommodations, Expenses - Caris MPI
 
George R. Blumenschein
Honoraria - Bayer; Bristol-Myers Squibb; Celgene; Novartis
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Celgene; Novartis
Travel, Accommodations, Expenses - Bayer; Celgene
 
Lee Steven Schwartzberg
Leadership - Vector Oncology
Consulting or Advisory Role - Amgen; Eisai; Genentech; Teva
Speakers' Bureau - Eisai; Genentech; Novartis
Research Funding - Eisai
 
Howard Burris
No Relationships to Disclose
 
David Waterhouse
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene
Speakers' Bureau - Celgene; Genentech
 
Robert M. Jotte
No Relationships to Disclose
 
Maen Hussein
Consulting or Advisory Role - Millennium
Speakers' Bureau - AMAG Pharmaceuticals; Millennium; Novartis
 
David R. Spigel
No Relationships to Disclose
 
Dana Shelton Thompson
Honoraria - Alexion Pharmaceuticals; Amgen; Celgene
Speakers' Bureau - Alexion Pharmaceuticals; Amgen; Celgene
 
Xuemei Li
Employment - Bristol-Myers Squibb; Celgene (I)
Stock and Other Ownership Interests - Bristol-Myers Squibb; Celgene (I); Juno Therapeutics; Kite, a Gilead company; Merck; Pfizer
Patents, Royalties, Other Intellectual Property - MIT is the owner of the patents that my husband is an author. (I)
 
Craig H. Reynolds
Stock and Other Ownership Interests - Gilead Sciences
Honoraria - Boehringer Ingelheim; Celgene; Genentech; Lilly
Consulting or Advisory Role - Boehringer Ingelheim; Genentech
Speakers' Bureau - Boehringer Ingelheim; Celgene; Genentech; Lilly
Travel, Accommodations, Expenses - Lilly